Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

SHA:688016 Revenue

In the year 2025, Shanghai MicroPort Endovascular MedTech had annual revenue of 1.35B CNY with 11.96% growth. Shanghai MicroPort Endovascular MedTech had revenue of 335.85M in the quarter ending December 31, 2025, with 41.85% growth.

• Revenue: 1.35B
• Revenue Growth: +11.96%
• P/S Ratio: 9.61
• Revenue / Employee: 1.64M
• Employees: 832
• Market Cap: 12.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.35B	144.31M	11.96%
Dec 31, 2024	1.21B	19.12M	1.61%
Dec 31, 2023	1.19B	290.70M	32.43%
Dec 31, 2022	896.50M	211.87M	30.95%
Dec 31, 2021	684.63M	214.38M	45.59%